GRK2 negatively regulates IGF-1R signaling pathway and cyclins' expression in HepG2 cells

Journal of Cellular Physiology

Volumn 228, Issue 9, 2013, Pages 1897-1901

  Wei, Zhengyu ^a,c   Hurtt, Reginald ^a   Gu, Tina ^a   Bodzin, Adam S ^a   Koch, Walter J ^b   Doria, Cataldo ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN E; G PROTEIN COUPLED RECEPTOR KINASE 2; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; SOMATOMEDIN C RECEPTOR;

ARTICLE; CONTROLLED STUDY; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; M PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CYCLIN A; CYCLIN B1; CYCLIN E; G-PROTEIN-COUPLED RECEPTOR KINASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 84878222518     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24353     Document Type: Article

References (30)

1. Aragay AM, Ruiz-Gomez A, Penela P, Sarnago S, Elorza A, Jimenez-Sainz MC, Mayor F, Jr. 1998. G protein-coupled receptor kinase 2 (GRK2): Mechanisms of regulation and physiological functions. FEBS Lett 430:37-40.
2. Arnon TI, Xu Y, Lo C, Pham T, An J, Coughlin S, Dorn GW, Cyster JG. 2011. GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood. Science 333:1898-1903.
3. Baserga R, Peruzzi F, Reiss K. 2003. The IGF-1 receptor in cancer biology. Int J Cancer 107:873-877.
4. Bodzin AS, Wei Z, Hurtt R, Gu T, Doria C. 2012. Gefitinib resistance in HCC Mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation. J Cell Physiol 227:2947-2952.
5. Chen Y, Li S, Tong C, Zhao Y, Wang B, Liu Y, Jia J, Jiang J. 2010. G protein-coupled receptor kinase 2 promotes high-level Hedgehog signaling by regulating the active state of Smo through kinase-dependent and kinase-independent mechanisms in Drosophila. Genes Dev 24:2054-2067.
6. Ciccarelli M, Chuprun JK, Rengo G, Gao E, Wei Z, Peroutka RJ, Gold JI, Gumpert A, Chen M, Otis NJ, Dorn GW, II, Trimarco B, Iaccarino G, Koch WJ. 2011. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation 123:1953-1962.
7. Cipolletta E, Campanile A, Santulli G, Sanzari E, Leosco D, Campiglia P, Trimarco B, Iaccarino G. 2009. The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. Cardiovasc Res 84:407-415.
8. Desbois-Mouthon C, Baron A, Blivet-Van Eggelpoel MJ, Fartoux L, Venot C, Bladt F, Housset C, Rosmorduc O. 2009. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: Rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Clin Cancer Res 15:5445-5456.
9. Fusco A, Santulli G, Sorriento D, Cipolletta E, Garbi C, Dorn GW, II, Trimarco B, Feliciello A, Iaccarino G. 2011. Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell Signal 24:468-475.
10. Garcia-Guerra L, Nieto-Vazquez I, Vila-Bedmar R, Jurado-Pueyo M, Zalba G, Diez J, Murga C, Fernandez-Veledo S, Mayor F, Jr., Lorenzo M. 2010. G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes 59:2407-2417.
11. Gros R, Benovic JL, Tan CM, Feldman RD. 1997. G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest 99:2087-2093.
12. Hartog H, Wesseling J, Boezen HM, van der Graaf WT. 2007. The insulin-like growth factor 1 receptor in cancer: Old focus, new future. Eur J Cancer 43:1895-1904.
13. Hopfner M, Huether A, Sutter AP, Baradari V, Schuppan D, Scherubl H. 2006. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells. Biochem Pharmacol 71:1435-1448.
14. Iaccarino G, Barbato E, Cipolletta E, De Amicis V, Margulies KB, Leosco D, Trimarco B, Koch WJ. 2005. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J 26:1752-1758.
15. Jiang X, Yang P, Ma L. 2009. Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development. Proc Natl Acad Sci USA 106:10183-10188.
16. Leosco D, Fortunato F, Rengo G, Iaccarino G, Sanzari E, Golino L, Zincarelli C, Canonico V, Marchese M, Koch WJ, Rengo F. 2007. Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. Neurosci Lett 415:279-282.
17. Lombardi MS, Kavelaars A, Schedlowski M, Bijlsma JW, Okihara KL, Van de Pol M, Ochsmann S, Pawlak C, Schmidt RE, Heijnen CJ. 1999. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J 13:715-725.
18. Metaye T, Levillain P, Kraimps JL, Perdrisot R. 2008. Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas. J Endocrinol 198:101-110.
19. Penela P, Ribas C, Aymerich I, Eijkelkamp N, Barreiro O, Heijnen CJ, Kavelaars A, Sanchez-Madrid F, Mayor F, Jr. 2008. G protein-coupled receptor kinase 2 positively regulates epithelial cell migration. EMBO J 27:1206-1218.
20. Penela P, Murga C, Ribas C, Lafarga V, Mayor F, Jr. 2010a. The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol 160:821-832.
21. Penela P, Rivas V, Salcedo A, Mayor F, Jr. 2010b. G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression. Proc Natl Acad Sci USA 107:1118-1123.
22. Ribas C, Penela P, Murga C, Salcedo A, Garcia-Hoz C, Jurado-Pueyo M, Aymerich I, Mayor F, Jr. 2007. The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 1768:913-922.
23. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L. 2003. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401-406.
24. Salcedo A, Mayor F, Jr., Penela P. 2006. Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. EMBO J 25:4752-4762.
25. Sehat B, Tofigh A, Lin Y, Trocme E, Liljedahl U, Lagergren J, Larsson O. 2010. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 3:ra10.
26. Shahid G, Hussain T. 2007. GRK2 negatively regulates glycogen synthesis in mouse liver FL83B cells. J Biol Chem 282:20612-20620.
27. Usui I, Imamura T, Satoh H, Huang J, Babendure JL, Hupfeld CJ, Olefsky JM. 2004. GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J 23:2821-2829.
28. Valentinis B, Baserga R. 2001. IGF-I receptor signalling in transformation and differentiation. Mol Pathol 54:133-137.
29. Vroon A, Kavelaars A, Limmroth V, Lombardi MS, Goebel MU, Van Dam AM, Caron MG, Schedlowski M, Heijnen CJ. 2005. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 174:4400-4406.
30. Wei Z, Hurtt R, Ciccarelli M, Koch WJ, Doria C. 2012. Growth inhibition of human hepatocellular carcinoma cells by overexpression of G protein-coupled receptor kinase 2. J Cell Physiol 227:2371-2377.